Hydrophilic or Lipophilic Statins?

Frontiers in Cardiovascular Medicine
Elisenda ClimentJuan Pedro-Botet

Abstract

Drugs can be classified as hydrophilic or lipophilic depending on their ability to dissolve in water or in lipid-containing media. The predominantly lipophilic statins (simvastatin, fluvastatin, pitavastatin, lovastatin and atorvastatin) can easily enter cells, whereas hydrophilic statins (rosuvastatin and pravastatin) present greater hepatoselectivity. Although the beneficial role of statins in primary and secondary cardiovascular prevention has been unequivocally confirmed, the possible superiority of one statin or other regarding their solubility profile is still not well-established. In this respect, although some previously published observational studies and clinical trials observed a superiority of lipophilic statins in cardiovascular outcomes, these results could also be explained by a greater low-density lipoprotein cholesterol reduction with this statin type. On the other hand, previous studies reported conflicting results as to the possible superiority of one statin type over the other regarding heart failure outcomes. Furthermore, adverse events with statin therapy may also be related to their solubility profile. Thus, the aim of the present review was to collect clinical evidence on possible differences in cardiova...Continue Reading

References

Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
May 22, 2002·Journal of the American College of Cardiology·Henry Krum, John J McMurray
Apr 24, 2003·Clinical Cardiology·James M McKenney
Mar 5, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN REVERSAL Investigators
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Apr 28, 2004·The American Journal of Cardiology·Dariush MozaffarianWayne C Levy
Jan 22, 2005·Fundamental & Clinical Pharmacology·Michael Schachter
Feb 3, 2006·Cardiovascular Drugs and Therapy·Eric BruckertBernard Bégaud
Mar 17, 2006·Biochemical Pharmacology·Svitlana DemyanetsJohann Wojta
Jun 6, 2006·Journal of the American College of Cardiology·Benjamin M SciricaUNKNOWN PROVE IT-TIMI 22 Investigators
Aug 28, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomohiro SakamotoUNKNOWN MUSASHI-AMI Investigators
Nov 7, 2007·The New England Journal of Medicine·John KjekshusUNKNOWN CORONA Group
Dec 11, 2007·Trends in Molecular Medicine·Chao-Yung WangJames K Liao
Apr 25, 2008·Heart Failure Clinics·Tamara B Horwich, Holly R Middlekauff
Dec 2, 2008·International Journal of Cardiology·Rui-qin XieJing-chao Lu
Oct 20, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Keizo NishiyamaMinoru Horie
Dec 8, 2009·The American Journal of Cardiology·Michael J LipinskiGeorge W Vetrovec
Apr 29, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Qian Zhou, James K Liao
Jul 9, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Takayoshi TsutamotoMinoru Horie
Oct 22, 2011·The Korean Journal of Internal Medicine·Min Chul KimJung Chaee Kang
Dec 28, 2011·International Journal of Cardiology·Hisato Takagi, Takuya Umemoto
Jun 29, 2013·Vascular Health and Risk Management·Kwadwo Osei BonsuDaniel Diamond Reidpath
Sep 13, 2013·The Cochrane Database of Systematic Reviews·Rod S TaylorShah Ebrahim
Nov 28, 2013·Clinical Science·Philip J Millar, John S Floras
Feb 12, 2014·Hypertension·Ali JavaheriShahrokh Javaheri

❮ Previous
Next ❯

Citations

Dec 7, 2021·European Journal of Preventive Cardiology·Elena OlmastroniManuela Casula

❮ Previous
Next ❯

Software Mentioned

CORONA
GISSI Gruppo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.